Pacemaker & ICD İmplantasyonu

British Heart Foundation. Pacemakers. Available online: http://www.bhf.org.uk/heart-health/treatment/ pacemakers.aspx

American Heart Association. Available online: http://www.heart.org/HEARTORG/Conditions/Arrhythmia/PreventionTreatmentofArrhythmia/Artificial-Pacemaker

Heart rhythm devices. UK National Clinical Audit 2009.

Yarlagadda C, Lange RA. Permanent Pacemaker Insertion Technique. Available online: http://emedicine.medscape. com/article/1839735-overview

Essebag V, Verma A, Healey JS, Krahn AD, Kalfon E, Coutu B et al. Clinically significant pocket hematoma increases long-term risk of device infection: BRUISE CONTROL INFECTION Study. J Am Coll Cardiol 2016;67:1300–8.

Sticherling C, Marin F, Birnie D, Boriani G, Calkins H, Dan GA et al.; ESC Scientific Document Group. Antithrombotic management in patients undergoing electrophysiological procedures: a European Heart Rhythm Association (EHRA) position document endorsed by the ESC Working Group Thrombosis, Heart Rhythm Society (HRS), and Asia Pacific Heart Rhythm Society (APHRS). Europace 2015;17:1197–214.

WHO. Global Guidelines for the Prevention of Surgical Site Infection. WHO Document Production Services, 2016.

Bischoff P, Kubilay NZ, Allegranzi B, Egger M, Gastmeier P. Effect of laminar airflow ventilation on surgical site infections: a systematic review and meta-analysis. Lancet Infect Dis 2017;17:553–61.

Lokhandwala D, Gupta A, Desai V, Panicker GK, Vora A. A pilot study comparing two sites for incision during pacemaker implantation and their influence on the scar. Indian Heart J 2018;70:704–8.

Tanawuttiwat T, Thisayakorn P, Viles-Gonzalez JF. LAST (local anesthetic systemic toxicity) but not least: systemic lidocaine toxicity during cardiac intervention. J Invasive Cardiol 2014;26:E13–15.

Ilov N, Ilov N, Nechepurenko A, Abdulkadyrov A, Paskeev D, Damrina E et al. Arguments to apply epinephrine for pocket hematoma reduction. The MAITRE study. J Atr Fibrillation 2016;9:1391.

Lipscomb KJ, Linker NJ, Fitzpatrick AP. Subpectoral implantation of a cardioverter defibrillator under local anaesthesia. Heart 1998;79:253–5.

Klug D, Balde M, Pavin D, Hidden-Lucet F, Clementy J, Sadoul N et al. Risk factors related to infections of implanted pacemakers and cardioverterdefibrillators: results of a large prospective study. Circulation 2007;116:1349–55.

Bongiorni MG, Proclemer A, Dobreanu D, Marinskis G, Pison L, Blomstrom-Lundqvist C et al.; conducted by the Scientific Initiative Committee, European Heart Rhythm Association. Preferred tools and techniques for implantation of cardiac electronic devices in Europe: results of the European Heart Rhythm Association survey. Europace 2013;15:1664–8.

Benz AP, Vamos M, Erath JW, Hohnloser SH. Cephalic vs. subclavian lead implantation in cardiac implantable electronic devices: a systematic review and meta-analysis. Europace 2019;21:121–9.

Atti V, Turagam MK, Garg J, Koerber S, Angirekula A, Gopinathannair R et al. Subclavian and axillary vein access versus cephalic vein cutdown for cardiac implantable electronic device implantation: a meta-analysis. JACC Clin Electrophysiol 2020;6:661–71.

Liu P, Zhou Y-F, Yang P, Gao Y-S, Zhao G-R, Ren S-Y et al. Optimized axillary vein technique versus subclavian vein technique in cardiovascular implantable electronic device implantation: a randomized controlled study. Chin Med J (Engl) 2016;129:2647–51.

Boule´ S, Marquie´ C, Vanesson-Bricout C, Kouakam C, Brigadeau F, Gue´don- Moreau L et al. Clopidogrel increases bleeding complications in patients undergoing heart rhythm device procedures. Pacing Clin Electrophysiol 2012;35: 605–11.

Lopez-Gil M, Fontenla A, Julia J, Parra JJ, Arribas F. Phrenic paralysis during cardiac electronic device implantation: incidence, causes and clinical course. Europace 2016;18:1561–4.

Bernstein NE, Aizer A, Chinitz LA. Use of a lateral infraclavicular puncture to obtain proximal venous access with occluded subclavian/axillary venous systems for cardiac rhythm devices. Pacing Clin Electrophysiol 2014;37:1017–22.

Chan NY, Kwong NP, Cheong AP. Venous access and long-term pacemaker lead failure: comparing contrast-guided axillary vein puncture with subclavian puncture and cephalic cutdown. Europace 2017;19:1193–7.

Abu-El-Haija B, Bhave PD, Campbell DN, Mazur A, Hodgson-Zingman DM, Cotarlan V et al. Venous stenosis after transvenous lead placement: a study of outcomes and risk factors in 212 consecutive patients. J Am Heart Assoc 2015;4: e001878.

Haran Burri et all. EHRA expert consensus statement and practical guide on optimal implantation technique for conventional pacemakers and implantable cardioverter-defibrillators: endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), and the Latin-American Heart Rhythm Society (LAHRS), EP Europace, Volume 23, Issue 7, July 2021, Pages 983–1008

Cano O, Andres A, Alonso P, Osca J, Sancho-Tello MJ, Olague J. Incidence and predictors of clinically relevant cardiac perforation associated with systematic implantation of active-fixation pacing and defibrillation leads: a single-centre experience with over 3800 implanted leads. Europace 2017;19:96–102.

Burri H, Sekoranja L. A misguided lead. Eur Heart J 2015;36:280.

Hussain MA, Furuya-Kanamori LUIS, Kaye G, Clark J, Doi SAR. The effect of right ventricular apical and nonapical pacing on the short- and long-term changes in left ventricular ejection fraction: a systematic review and metaanalysis of randomized-controlled trials. Pacing Clin Electrophysiol 2015;38: 1121–36.

Saito M, Iannaccone A, Kaye G, Negishi K, Kosmala W, Marwick TH. Effect of right ventricular pacing on right ventricular mechanics and tricuspid regurgitation in patients with high-grade atrioventricular block and sinus rhythm (from the protection of left ventricular function during right ventricular pacing study). Am J Cardiol 2015;116:1875–82.

Witt CM, Lenz CJ, Shih HH, Ebrille E, Rosenbaum AN, Aung H et al. Right atrial lead fixation type and lead position are associated with significant variation in complications. J Interv Card Electrophysiol 2016;47:313–9.

Zeitler EP, Sanders GD, Singh K, Greenfield RA, Gillis AM, Wilkoff BL et al. Single vs. dual chamber implantable cardioverter-defibrillators or programming of implantable cardioverter-defibrillators in patients without a bradycardia pacing indication: systematic review and meta-analysis. Europace 2018;20:1621–9.

Darda S, Khouri Y, Gorges R, Al Samara M, Jain SK, Daccarett M et al. Feasibility and safety of same-day discharge after implantable cardioverter defibrillator placement for primary prevention. Pacing Clin Electrophysiol 2013;36: 885–91.

Guo Y, Xie C, Rodriguez RM, et al. Factors related to recurrence of spontaneous pneumothorax. Respirology 2005;10:378-84.

Pakarinen S, Oikarinen L, Toivonen L. Short-term implantation-related complications of cardiac rhythm management device therapy: a retrospective single-centre 1-year survey. Europace 2010;12:103-8.

Link MS, Estes NA 3rd, Griffin JJ, et al. Complications of dual chamber pacemaker implantation in the elderly. Pacemaker Selection in the Elderly (PASE) Investigators. J Interv Card Electrophysiol 1998;2:175-9.

Reynolds MR, Cohen DJ, Kugelmass AD, et al. The frequency and incremental cost of major complications among medicare beneficiaries receiving implantable cardioverter-defibrillators. J Am Coll Cardiol 2006;47:2493-7

British Heart Foundation. Pacemakers. Available online: http://www.bhf.org.uk/heart-health/treatment/ pacemakers.aspx

American Heart Association. Available online: http://www.heart.org/HEARTORG/Conditions/Arrhythmia/PreventionTreatmentofArrhythmia/Artificial-Pacemaker

Heart rhythm devices. UK National Clinical Audit 2009.

Yarlagadda C, Lange RA. Permanent Pacemaker Insertion Technique. Available online: http://emedicine.medscape. com/article/1839735-overview

Essebag V, Verma A, Healey JS, Krahn AD, Kalfon E, Coutu B et al. Clinically significant pocket hematoma increases long-term risk of device infection: BRUISE CONTROL INFECTION Study. J Am Coll Cardiol 2016;67:1300–8.

Sticherling C, Marin F, Birnie D, Boriani G, Calkins H, Dan GA et al.; ESC Scientific Document Group. Antithrombotic management in patients undergoing electrophysiological procedures: a European Heart Rhythm Association (EHRA) position document endorsed by the ESC Working Group Thrombosis, Heart Rhythm Society (HRS), and Asia Pacific Heart Rhythm Society (APHRS). Europace 2015;17:1197–214.

WHO. Global Guidelines for the Prevention of Surgical Site Infection. WHO Document Production Services, 2016.

Bischoff P, Kubilay NZ, Allegranzi B, Egger M, Gastmeier P. Effect of laminar airflow ventilation on surgical site infections: a systematic review and meta-analysis. Lancet Infect Dis 2017;17:553–61.

Lokhandwala D, Gupta A, Desai V, Panicker GK, Vora A. A pilot study comparing two sites for incision during pacemaker implantation and their influence on the scar. Indian Heart J 2018;70:704–8.

Tanawuttiwat T, Thisayakorn P, Viles-Gonzalez JF. LAST (local anesthetic systemic toxicity) but not least: systemic lidocaine toxicity during cardiac intervention. J Invasive Cardiol 2014;26:E13–15.

Ilov N, Ilov N, Nechepurenko A, Abdulkadyrov A, Paskeev D, Damrina E et al. Arguments to apply epinephrine for pocket hematoma reduction. The MAITRE study. J Atr Fibrillation 2016;9:1391.

Lipscomb KJ, Linker NJ, Fitzpatrick AP. Subpectoral implantation of a cardioverter defibrillator under local anaesthesia. Heart 1998;79:253–5.

Klug D, Balde M, Pavin D, Hidden-Lucet F, Clementy J, Sadoul N et al. Risk factors related to infections of implanted pacemakers and cardioverterdefibrillators: results of a large prospective study. Circulation 2007;116:1349–55.

Bongiorni MG, Proclemer A, Dobreanu D, Marinskis G, Pison L, Blomstrom-Lundqvist C et al.; conducted by the Scientific Initiative Committee, European Heart Rhythm Association. Preferred tools and techniques for implantation of cardiac electronic devices in Europe: results of the European Heart Rhythm Association survey. Europace 2013;15:1664–8.

Benz AP, Vamos M, Erath JW, Hohnloser SH. Cephalic vs. subclavian lead implantation in cardiac implantable electronic devices: a systematic review and meta-analysis. Europace 2019;21:121–9.

Atti V, Turagam MK, Garg J, Koerber S, Angirekula A, Gopinathannair R et al. Subclavian and axillary vein access versus cephalic vein cutdown for cardiac implantable electronic device implantation: a meta-analysis. JACC Clin Electrophysiol 2020;6:661–71.

Liu P, Zhou Y-F, Yang P, Gao Y-S, Zhao G-R, Ren S-Y et al. Optimized axillary vein technique versus subclavian vein technique in cardiovascular implantable electronic device implantation: a randomized controlled study. Chin Med J (Engl) 2016;129:2647–51.

Boule´ S, Marquie´ C, Vanesson-Bricout C, Kouakam C, Brigadeau F, Gue´don- Moreau L et al. Clopidogrel increases bleeding complications in patients undergoing heart rhythm device procedures. Pacing Clin Electrophysiol 2012;35: 605–11.

Lopez-Gil M, Fontenla A, Julia J, Parra JJ, Arribas F. Phrenic paralysis during cardiac electronic device implantation: incidence, causes and clinical course. Europace 2016;18:1561–4.

Bernstein NE, Aizer A, Chinitz LA. Use of a lateral infraclavicular puncture to obtain proximal venous access with occluded subclavian/axillary venous systems for cardiac rhythm devices. Pacing Clin Electrophysiol 2014;37:1017–22.

Chan NY, Kwong NP, Cheong AP. Venous access and long-term pacemaker lead failure: comparing contrast-guided axillary vein puncture with subclavian puncture and cephalic cutdown. Europace 2017;19:1193–7.

Abu-El-Haija B, Bhave PD, Campbell DN, Mazur A, Hodgson-Zingman DM, Cotarlan V et al. Venous stenosis after transvenous lead placement: a study of outcomes and risk factors in 212 consecutive patients. J Am Heart Assoc 2015;4: e001878.

Haran Burri et all. EHRA expert consensus statement and practical guide on optimal implantation technique for conventional pacemakers and implantable cardioverter-defibrillators: endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), and the Latin-American Heart Rhythm Society (LAHRS), EP Europace, Volume 23, Issue 7, July 2021, Pages 983–1008

Cano O, Andres A, Alonso P, Osca J, Sancho-Tello MJ, Olague J. Incidence and predictors of clinically relevant cardiac perforation associated with systematic implantation of active-fixation pacing and defibrillation leads: a single-centre experience with over 3800 implanted leads. Europace 2017;19:96–102.

Burri H, Sekoranja L. A misguided lead. Eur Heart J 2015;36:280.

Hussain MA, Furuya-Kanamori LUIS, Kaye G, Clark J, Doi SAR. The effect of right ventricular apical and nonapical pacing on the short- and long-term changes in left ventricular ejection fraction: a systematic review and metaanalysis of randomized-controlled trials. Pacing Clin Electrophysiol 2015;38: 1121–36.

Saito M, Iannaccone A, Kaye G, Negishi K, Kosmala W, Marwick TH. Effect of right ventricular pacing on right ventricular mechanics and tricuspid regurgitation in patients with high-grade atrioventricular block and sinus rhythm (from the protection of left ventricular function during right ventricular pacing study). Am J Cardiol 2015;116:1875–82.

Witt CM, Lenz CJ, Shih HH, Ebrille E, Rosenbaum AN, Aung H et al. Right atrial lead fixation type and lead position are associated with significant variation in complications. J Interv Card Electrophysiol 2016;47:313–9.

Zeitler EP, Sanders GD, Singh K, Greenfield RA, Gillis AM, Wilkoff BL et al. Single vs. dual chamber implantable cardioverter-defibrillators or programming of implantable cardioverter-defibrillators in patients without a bradycardia pacing indication: systematic review and meta-analysis. Europace 2018;20:1621–9.

Darda S, Khouri Y, Gorges R, Al Samara M, Jain SK, Daccarett M et al. Feasibility and safety of same-day discharge after implantable cardioverter defibrillator placement for primary prevention. Pacing Clin Electrophysiol 2013;36: 885–91.

Guo Y, Xie C, Rodriguez RM, et al. Factors related to recurrence of spontaneous pneumothorax. Respirology 2005;10:378-84.

Pakarinen S, Oikarinen L, Toivonen L. Short-term implantation-related complications of cardiac rhythm management device therapy: a retrospective single-centre 1-year survey. Europace 2010;12:103-8.

Link MS, Estes NA 3rd, Griffin JJ, et al. Complications of dual chamber pacemaker implantation in the elderly. Pacemaker Selection in the Elderly (PASE) Investigators. J Interv Card Electrophysiol 1998;2:175-9.

Reynolds MR, Cohen DJ, Kugelmass AD, et al. The frequency and incremental cost of major complications among medicare beneficiaries receiving implantable cardioverter-defibrillators. J Am Coll Cardiol 2006;47:2493-7